MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 73 filers reported holding MARRONE BIO INNOVATIONS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | +25.0% | 4,928 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -20.0% | 4,928 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +66.7% | 4,928 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 4,928 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -20.0% | 4,928 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -28.6% | 4,928 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | -12.5% | 4,928 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +14.3% | 4,928 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -22.2% | 4,928 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | – | 4,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 10,324,747 | $13,487,000 | 2.13% |
| ICM ASSET MANAGEMENT INC/WA | 258,900 | $388,000 | 0.29% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 561,702 | $843,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 24,714,892 | $37,072,000 | 0.09% |
| Fairpointe Capital LLC | 291,000 | $436,000 | 0.02% |
| Spark Investment Management LLC | 66,700 | $100,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,480,710 | $3,721,000 | 0.00% |
| A.R.T. Advisors, LLC | 18,829 | $28,000 | 0.00% |
| Allworth Financial LP | 11,266 | $17,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 73,678 | $111,000 | 0.00% |